Hermann, R.R.HermannSchneider, E.E.SchneiderMenth, M.M.MenthKnebel, N.N.KnebelFerron, G.G.FerronBorlak, J.J.BorlakErb, K.K.ErbPartiot, A.A.PartiotGermain, J.-M.J.-M.GermainLocher, M.M.LocherPorter, R.R.Porter2022-03-032022-03-032002https://publica.fraunhofer.de/handle/publica/202489The Sixth Eilat Conference on New Antieliptic Drugs (AEDs) took place in Taormina, Sicily, Italy from 7th to 11th April, 2002. Basic scientists, clinical pharmacologists and neurologists from 27 countries attended the conference, whose main themes included dose-response relationships with conventional and recent AEDs, teratogenic effects of conventional and recent AEDs, update on clinical implications of AED metabolism, prevention of epileptogesis, and seizure aggravation by AEDs. According to tradition, the central part of the conference was devoted to a review of AEDs in development, as well to updates on AEDs, which have been marketed in recent years.enantieliptic drugsepilepsyconferencedrug developmentpharmacologyclinical trial615610620616journal article